Eltroxin New Formulation
(2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 5819.
Registration
- Applicants
- 1
- Registrations
- 11
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Eltroxin new formulation 25 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 25,0 ug | 25 ug | 47061447/21.3/0614 | Registered | S3 | PIPIL |
| Eltroxin new formulation 50 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 50,0 ug | 50 ug | 47061547/21.3/0615 | Registered | S3 | PIPIL |
| Eltroxin new formulation 75 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 75,0 ug | 75 ug | 47061647/21.3/0616 | Registered | S3 | PIPIL |
| Eltroxin new formulation 88 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 88,0 ug | 88 ug | 47061747/21.3/0617 | Registered | S3 | PIPIL |
| Eltroxin new formulation 100 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 100,0 ug | 100 ug | 47061847/21.3/0618 | Registered | S3 | PIPIL |
| Eltroxin new formulation 112 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 112,0 ug | 112 ug | 47061947/21.3/0619 | Registered | S3 | PIPIL |
| Eltroxin new formulation 125 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 125,0 ug | 125 ug | 47062047/21.3/0620 | Registered | S3 | PIPIL |
| Eltroxin new formulation 137 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 137,0 ug | 137 ug | 47062147/21.3/0621 | Registered | S3 | PIPIL |
| Eltroxin new formulation 150 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 150,0 ug | 150 ug | 47062247/21.3/0622 | Registered | S3 | PIPIL |
| Eltroxin new formulation 175 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 175,0 ug | 175 ug | 47062347/21.3/0623 | Registered | S3 | PIPIL |
| Eltroxin new formulation 200 ug EACH TABLET CONTAINS LEVOTHYROXINE SODIUM 200,0 ug | 200 ug | 47062447/21.3/0624 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Levothyroxine sodium
S3: Levothyroxine
Consolidated Schedules 06 July 2026, line 3888
Pharmacological class: Thyroid preparations. (class 21.3)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
These documents come from SAHPRA's PI-PIL repository unless the line under a document says otherwise. Always consult with a healthcare professional for medical advice.